Breaking down barriers
Our activities and our collaboration with our partners is led by our overarching commitment in promoting health innovation and R&D to achieve our SDG targets by 2030 and beyond. While promoting awareness raising amongst policymakers and suggesting solutions, initiatives in tackling some of the world’s deadliest diseases such as malaria, tuberculosis, HIV and AIDS, sepsis and cardiovascular diseases and neglected tropical diseases, we focus on overarching challenges to drive system changes that can help to tackle these diseases in and between countries. We provide concrete solutions that help eradicate and tackle some of the world’s deadliest diseases.
Unlike traditional health advocacy groups our recommendations to the G20 and also the G7, our activities and our thought leadership is guided by a macro-economic lens on the overall global health advancement and health systems strengthening agenda. Our common mission and vision promote the risk-return-impact narrative in global health advancement guided by the UN SDG 2030 targets.
The global COVID-19 pandemic has highlighted that current and future health challenges do not respect borders. As the current pandemic will cost our economies and societies around 22 trillion USD by 2025 as estimated by the G20 High-Level Panel of Financing the Common Goods, our objective is to look at outcome-oriented scenarios with our partners and prevent any future disaster.